Literature DB >> 10235594

Gastric hemorrhage and ulceration in hiatal hernia sac associated with alendronate.

P S Kaye.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10235594     DOI： 10.1023/a:1026687925758

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  10 in total

1.  Alendronate-induced ulcerative esophagitis.

Authors:  M F Abdelmalek; D D Douglas
Journal:  Am J Gastroenterol       Date:  1996-06       Impact factor: 10.864

2.  From the Food and Drug Administration.

Authors:  S L Nightingale
Journal:  JAMA       Date:  1996 May 22-29       Impact factor: 56.272

3.  Multiple ulcerative esophagitis caused by alendronate.

Authors:  G Maconi; G Bianchi Porro
Journal:  Am J Gastroenterol       Date:  1995-10       Impact factor: 10.864

4.  Warning about oesophagitis with Fosamax.

Authors: 
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

5.  Effects of two oral doses of alendronate in the treatment of Paget's disease of bone.

Authors:  S Adami; M Mian; P Gatti; M Rossini; N Zamberlan; F Bertoldo; V Lo Cascio
Journal:  Bone       Date:  1994 Jul-Aug       Impact factor: 4.398

6.  Nonclinical model for assessing gastric effects of bisphosphonates.

Authors:  M A Blank; B L Ems; G W Gibson; W R Myers; S K Berman; R J Phipps; P N Smith
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

7.  Alendronate induces gastric injury and delays ulcer healing in rodents.

Authors:  S N Elliott; W McKnight; N M Davies; W K MacNaughton; J L Wallace
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

8.  Primary amino-bisphosphonates: a new class of gastrotoxic drugs--comparison of alendronate and aspirin.

Authors:  D Y Graham; H M Malaty; R Goodgame
Journal:  Am J Gastroenterol       Date:  1997-08       Impact factor: 10.864

9.  Short-term effect of alendronate on bone mass and bone remodeling in postmenopausal women.

Authors:  C H Chesnut; S T Harris
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

Review 10.  Esophagitis associated with the use of alendronate.

Authors:  P C de Groen; D F Lubbe; L J Hirsch; A Daifotis; W Stephenson; D Freedholm; S Pryor-Tillotson; M J Seleznick; H Pinkas; K K Wang
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245
  10 in total
  2 in total

Review 1.  A drinkable formulation of alendronate: potential to increase compliance and decrease upper GI irritation.

Authors:  Maria Luisa Brandi; Dennis Black
Journal:  Clin Cases Miner Bone Metab       Date:  2013-09

2.  Bisphosphonate increases risk of gastroduodenal ulcer in rheumatoid arthritis patients on long-term nonsteroidal antiinflammatory drug therapy.

Authors:  Kazumasa Miyake; Masanori Kusunoki; Yoko Shinji; Tomotaka Shindo; Tetsuro Kawagoe; Seiji Futagami; Katya Gudis; Taku Tsukui; Atsushi Nakajima; Choitsu Sakamoto
Journal:  J Gastroenterol       Date:  2009-02-13       Impact factor: 7.527
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.